Keyphrases
Breast Cancer Recurrence
20%
CA-125 Levels
40%
Carbohydrate Antigen 125 (CA125)
20%
Chemotherapeutic Regimens
20%
Clinical Benefit
20%
Complete Response
40%
Computed Tomography
20%
Disease Control
20%
Disease Progression
40%
Disease Response
20%
Disease Stabilization
20%
Epithelial Ovarian Cancer
100%
Estrogen Receptor
20%
Estrogen Receptor Antagonist
20%
Estrogen Receptor-positive
20%
Estrogen Therapy
20%
Fulvestrant
100%
Headache
20%
Inclusion Criteria
20%
Intolerance
20%
Measurable Disease
20%
Median Time
20%
Modified RECIST
20%
Objective Response Rate
20%
One Dose
20%
Ovarian Cancer
20%
Partial Response
40%
Phase II Study
100%
Physical Tests
20%
Primary Peritoneal Cancer
40%
RECIST Criteria
40%
Recurrent Ovarian Cancer
20%
Stable Disease
60%
Pharmacology, Toxicology and Pharmaceutical Science
Antiestrogen
14%
Breast Cancer
14%
Carcinoma
14%
Disease
100%
Disease Exacerbation
28%
Estrogen Receptor
28%
Estrogen Receptor Antagonist
14%
Fulvestrant
100%
Headache
14%
Ovary Cancer
28%
Ovary Carcinoma
100%
Peritoneum Cancer
14%